579
Views
0
CrossRef citations to date
0
Altmetric
Review

Tumor-Targeting Glycol Chitosan Nanoparticles as A Platform Delivery Carrier in Cancer Diagnosis and Therapy

, , , , , & show all
Pages 1697-1713 | Published online: 16 Oct 2014

References

  • Jemal A , BrayF, CenterMM, FerlayJ, WardE, FormanD. Global cancer statistics. CA Cancer J. Clin.61 (2), 69–90 (2011).
  • Cassileth BR , DengG. Complementary and Alternative Therapies for Cancer. Oncologist9 (1), 80–89 (2004).
  • Singhal V , SinghJ, LyallA, SaxenaS, BansalA. Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer? A prospective clinical study. BMC Cancer4 (1), 48 (2004).
  • Morelli D , MénardS, ColnaghiMI, BalsariA. Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice. Cancer Res.56 (9), 2082–2085 (1996).
  • Zhang D , HedlundE-ME, LimSet al. Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity. Proc. Natl Acad. Sci. USA108 (10), 4117–4122 (2011).
  • Suresh S . Nanomedicine: elastic clues in cancer detection. Nat. Nanotechnol.2 (12), 748–749 (2007).
  • Liu Y , MiyoshiH, NakamuraM. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer120 (12), 2527–2537 (2007).
  • Cheng Y , SamiaAC, LiJ, KenneyME, ResnickA, BurdaC. Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface. Langmuir26 (4), 2248–2255 (2009).
  • Perrault SD , ChanWC. In vivo assembly of nanoparticle components to improve targeted cancer imaging. Proc. Natl Acad. Sci. USA107 (25), 11194–11199 (2010).
  • Estévez MC , HuangY-F, KangHet al. Nanoparticle–aptamer conjugates for cancer cell targeting and detection . In:Cancer Nanotechnol. (Volume 624).GrobmyerSR & MoudgilBM (Eds)., Humana Press, NY, USA, 235–248 (2010).
  • Ruoslahti E , BhatiaSN, SailorMJ. Targeting of drugs and nanoparticles to tumors. J. Cell Biol.188 (6), 759–768 (2010).
  • Kim K , KimJH, ParkHet al. Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring. J. Control. Release146 (2), 219–227 (2010).
  • Byrne JD , BetancourtT, Brannon-PeppasL. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Del. Rev.60 (15), 1615–1626 (2008).
  • Cho K , WangX, NieS, ShinDM. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer. Res.14 (5), 1310–1316 (2008).
  • Peer D , KarpJM, HongS, FarokhzadOC, MargalitR, LangerR. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol.2 (12), 751–760 (2007).
  • Bhaskar S , TianF, StoegerTet al. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part. Fibre Toxicol.7 (3), 3 (2010).
  • Prabaharan M . Review Paper: chitosan derivatives as promising materials for controlled drug delivery. J. Biomater. Appl.23 (1), 5–36 (2008).
  • Felt O , BuriP, GurnyR. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm.24 (11), 979–993 (1998).
  • Park JH , SaravanakumarG, KimK, KwonIC. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Del. Rev.62 (1), 28–41 (2010).
  • Wang JJ , ZengZW, XiaoRZet al. Recent advances of chitosan nanoparticles as drug carriers. Int. J. Nanomed.6, 765 (2011).
  • Kean T , ThanouM. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug Del. Rev.62 (1), 3–11 (2010).
  • Agnihotri SA , MallikarjunaNN, AminabhaviTM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release100 (1), 5–28 (2004).
  • Pan Y , LiY-J, ZhaoH-Yet al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm.249 (1), 139–147 (2002).
  • Rudzinski WE , AminabhaviTM. Chitosan as a carrier for targeted delivery of small interfering RNA. Int. J. Pharm.399 (1–2), 1–11 (2010).
  • Peng H , LiW, NingFet al. Amphiphilic chitosan derivatives-based liposomes: synthesis, development and properties as a carrier for sustained release of salidroside. J. Agric. Food Chem.62 (3), 626–633 (2014).
  • Viegas De Souza RHF , TakakiM, De Oliveira PedroR, Dos Santos GabrielJ, TieraMJ, De Oliveira TieraVA. Hydrophobic effect of amphiphilic derivatives of chitosan on the antifungal activity against Aspergillus flavus and Aspergillus parasiticus. Molecules18 (4), 4437–4450 (2013).
  • Kim K , KimJ-H, KimSet al. Self-assembled nanoparticles of bile acid-modified glycol chitosans and their applications for cancer therapy. Macromol. Res.13 (3), 167–175 (2005).
  • Yu JM , LiYJ, QiuLY, JinY. Polymeric nanoparticles of cholesterol‐modified GC for doxorubicin delivery: preparation and in‐vitro and in‐vivo characterization. J. Pharm. Pharmacol.61 (6), 713–719 (2009).
  • Kim JH , KimYS, ParkKet al. Antitumor efficacy of cisplatin-loaded GC nanoparticles in tumor-bearing mice. J. Control. Release127 (1), 41–49 (2008).
  • Hwang H-Y , KimI-S, KwonIC, KimY-H. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified GC nanoparticles. J. Control. Release128 (1), 23–31 (2008).
  • Min KH , ParkK, KimY-Set al. Hydrophobically modified GC nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J. Control. Release127 (3), 208–218 (2008).
  • Kim J-H , KimY-S, KimSet al. Hydrophobically modified GC nanoparticles as carriers for paclitaxel. J. Control. Release111 (1), 228–234 (2006).
  • Na JH , KooH, LeeSet al. Real-time and non-invasive optical imaging of tumor-targeting GC nanoparticles in various tumor models. Biomaterials32 (22), 5252–5261 (2011).
  • Hillaireau H , CouvreurP. Nanocarriers' entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci.66 (17), 2873–2896 (2009).
  • Nam HY , KwonSM, ChungHet al. Cellular uptake mechanism and intracellular fate of hydrophobically modified GC nanoparticles. J. Control. Release135 (3), 259–267 (2009).
  • Park K , KimJH, NamYSet al. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled GC nanoparticles. J. Control. Release122 (3), 305–314 (2007).
  • Na JH , LeeSY, LeeSet al. Effect of the stability and deformability of self-assembled GC nanoparticles on tumor-targeting efficiency. J. Control. Release163 (1), 2–9 (2012).
  • Yuk SH , OhKS, ChoSHet al. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging. Biomacromolecules12 (6), 2335–2343 (2011).
  • Crayton SH , TsourkasA. pH-titratable superparamagnetic iron oxide for improved nanoparticle accumulation in acidic tumor microenvironments. ACS Nano5 (12), 9592–9601 (2011).
  • De Luca E , HarveyP, ChalmersKHet al. Characterisation and evaluation of paramagnetic fluorine labelled GC conjugates for F and H magnetic resonance imaging. J. Biol. Inorg. Chem.19 (2), 215–227 (2013).
  • Nam T , ParkS, LeeS-Yet al. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging. Bioconj. Chem.21 (4), 578–582 (2010).
  • Sun IC , EunDK, KooHet al. Tumor-targeting gold particles for dual computed tomography/optical cancer imaging. Angew. Chem. Int. Ed.50 (40), 9348–9351 (2011).
  • Sun IC , NaJH, JeongSYet al. Biocompatible glycol chitosan-coated gold nanoparticles for tumor-targeting CT imaging. Pharm. Res.1–8 (2013).
  • Kim DE , KimJY, SunICet al. Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles. Ann. Neurol.73 (5), 617–625 (2013).
  • Lee D-E , NaJH, LeeSet al. Facile method to radiolabel GC nanoparticles with 64Cu via copper-free click chemistry for microPET imaging. Mol. Pharm.10 (6), 2190–2198 (2013).
  • Kang E , MinHS, LeeJet al. Nanobubbles from gas‐generating polymeric nanoparticles: ultrasound imaging of living subjects. Angew. Chem. Int. Ed.49 (3), 524–528 (2010).
  • Koo H , MinKH, LeeSCet al. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated GC nanoparticles for tumor-targeted paclitaxel delivery. J. Control. Release172 (3), 823–831 (2013).
  • Son YJ , JangJ-S, ChoYWet al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J. Control. Release91 (1), 135–145 (2003).
  • Lee BS , ParkK, ParkSet al. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug. J. Control. Release147 (2), 253–260 (2010).
  • Meng L , HuangW, WangD, HuangX, ZhuX, YanD. Chitosan-based nanocarriers with pH and light dual response for anticancer drug delivery. Biomacromolecules14 (8), 2601–2610 (2013).
  • Kim JH , KimYS, ParkKet al. Self-assembled GC nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials29 (12), 1920–1930 (2008).
  • Lee SJ , KooH, JeongHet al. Comparative study of photosensitizer loaded and conjugated GC nanoparticles for cancer therapy. J. Control. Release152 (1), 21–29 (2011).
  • Lee SJ , KooH, LeeDEet al. Tumor-homing photosensitizer-conjugated GC nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials32 (16), 4021–4029 (2011).
  • Oh IH , MinHS, LiLet al. Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice. Biomaterials34 (27), 6454–6463 (2013).
  • Kim S , LeeDJ, KwagDS, LeeUY, YounYS, LeeES. Acid pH-activated glycol chitosan/fullerene nanogels for efficient tumor therapy. Carbohydr. Polym.101, 692–698 (2014).
  • Kwag DS , OhNM, OhYT, OhKT, YounYS, LeeES. Photodynamic therapy using GC grafted fullerenes. Int. J. Pharm.431 (1–2), 204–209 (2012).
  • Yoo HS , LeeJE, ChungH, KwonIC, JeongSY. Self-assembled nanoparticles containing hydrophobically modified GC for gene delivery. J. Control. Release103 (1), 235–243 (2005).
  • Huh MS , LeeSY, ParkSet al. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J. Control. Release144 (2), 134–143 (2010).
  • Lee SJ , HuhMS, LeeSYet al. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment. Angew. Chem. Int. Ed.51 (29), 7203–7207 (2012).
  • Park JH , KwonS, NamJ-Oet al. Self-assembled nanoparticles based on GC bearing 5β-cholanic acid for RGD peptide delivery. J. Control. Release95 (3), 579–588 (2004).
  • Dolmans DE , FukumuraD, JainRK. Photodynamic therapy for cancer. Nat. Rev. Cancer3 (5), 380–387 (2003).
  • Al-Dosari MS , GaoX. Nonviral gene delivery: principle, limitations, and recent progress. The AAPS journal11 (4), 671–681 (2009).
  • Köping-Höggård M , TubulekasI, GuanHet al. Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther.8 (14), (2001).
  • Köping-Höggård M , VårumK, IssaMet al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther.11 (19), 1441–1452 (2004).
  • Hannon GJ . RNA interference. Nature418 (6894), 244–251 (2002).
  • Whitehead KA , LangerR, AndersonDG. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov.8 (2), 129–138 (2009).
  • Lee SJ , SonS, YheeJYet al. Structural modification of siRNA for efficient gene silencing. Biotechnol. Adv.31 (5), 491–503 (2013).
  • Lee S-Y , HuhMS, LeeSet al. Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes for efficient gene silencing. J. Control. Release141 (3), 339–346 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.